Samson,Thanks for the post and nice summation.I am new holder...

Samson,

Thanks for the post and nice summation.
I am new holder (buying in with MR came on board).

Regarding your post- I think you have answered your question..IMO for a biotech with a market cap of circa $12m, it does not have all its fingers in one basket and this has to be a good thing. Seeing the SP decine over the last 6 months gives you that flat feeling ...but I think the upcoming AGM should give some news regarding likely company developments in thew coming 6 to 12 months.

Also whilst Lind Funding arrangement can be disenchanting at times to the SP, it also serves a major buffer in keeping the company alive and allowing management to pursue company goals. INDIRECTLY it also gives a major vote of confidance to the Board and the prospects of Consegna..because in these trying times these astute but unmerciful equity investors would not even return an email had they believed that Consegna was not going to return $$$$ to their stakeholders.

Looking fwd to the AGM update.

The above are my views only so please DYOR.